CAMP4 Therapeutics Corporation (CAMP) vs Upstream Bio, Inc. (UPB)
A side-by-side comparison of CAMP4 Therapeutics Corporation and Upstream Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAMP
CAMP4 Therapeutics Corporation
$3.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
UPB
Upstream Bio, Inc.
$4.59HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CAMP vs UPB
growth of $100 · dividends reinvested · last 2yCAMP -62.6% (-38.8%/yr)UPB -78.0% (-53.0%/yr)CAMP compounded faster over this window
CAMP UPB
CAMP vs UPB: by the numbers
- •UPB is the larger company ($250M vs $249M market cap).
- •Both run net losses; CAMP's is the smaller (-2543.74% vs -4955.67% net margin).
Metrics side by side
Valuation
| Metric | CAMP | UPB |
|---|---|---|
| P/S ratio | 58.94 | 79.10 |
| P/B ratio | N/A | 0.92 |
Profitability
| Metric | CAMP | UPB |
|---|---|---|
| Gross margin | 53.14% | 98.45% |
| Operating margin | -1488.31% | -5618.82% |
| Net margin | -2543.74% | -4955.67% |
| ROE | N/A | -57.76% |
| ROIC | -69.76% | -62.51% |
Growth (annualized)
| Metric | CAMP | UPB |
|---|---|---|
| Revenue CAGR (5Y) | -57.68% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.